Novel Chimeric Immuno-Oncolytic Virus CF33-hNIS-antiPDL1 for the Treatment of Pancreatic Cancer
Affiliation:
1. Department of Surgery, City of Hope National Medical Center, Duarte, CA;2. Cancer Immunotherapeutics Program, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA;3. Translational Genomics Research Institute (TGen), Phoenix, AZ;1. Department of Surgery, University of Alabama at Birmingham, Birmingham, AL;2. Department of Eastern Virginia Medical School, Norfolk, VA;1. Department of Hematology Oncology, Wake Forest University, Winston-Salem, NC;2. Department of Public Health Sciences, Wake Forest University, Winston-Salem, NC;3. Surgical Oncology Service, Department of General Surgery, Wake Forest University, Winston-Salem, NC;1. Jefferson Pancreas, Biliary, and Related Cancer Center, Department of Surgery, Thomas Jefferson University, Philadelphia, PA;2. Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA;3. Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA
